文献速递系统性红斑狼疮

狼疮 flare 在透析患者中比肾移植后受者更常见:系统评价与荟萃分析

Lupus Flares: More Common in Dialysis Patients Than in Post-Kidney Transplant Recipients: A Systematic Review and Meta-Analysis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2025-03-13

该系统评价与荟萃分析检索1973至2023年文献,纳入57项研究,评估终末期肾病及肾脏替代治疗(血液透析、腹膜透析、肾移植)后系统性红斑狼疮 flare 的频率;结果显示35.9%的终末期肾病患者在肾脏替代治疗后至少发生一次肾外 flare,透析患者 flare 风险显著高于肾移植受者(OR 4.36,95%CI 1.66-11.47,P=0.0028),而血液透析与腹膜透析之间无显著差异(OR 1.05,95%CI 0.57-1.94),肾移植后狼疮肾炎复发率为3.39%。

要点

  • 35.9%的终末期肾病患者在肾脏替代治疗后至少发生一次肾外狼疮 flare。
  • 透析患者肾外 flare 风险显著高于肾移植受者(OR 4.36,95%CI 1.66-11.47,P=0.0028)。
  • 血液透析与腹膜透析的肾外 flare 频率相似(OR 1.05,95%CI 0.57-1.94),肾移植后狼疮肾炎复发率为3.39%。

核心结论

  • 接受肾脏替代治疗的终末期肾病患者中仍有超过三分之一发生肾外狼疮 flare。
  • 透析患者的 flare 风险高于肾移植后患者,而血液透析与腹膜透析患者的 flare 风险相当。

研究设计与样本

  • 系统文献复习与荟萃分析,检索1973年至2023年关于肾脏替代治疗后狼疮 flare 频率的研究。
  • 共57项研究符合研究入选标准,其中29项评估血液透析/腹膜透析后肾外狼疮 flare,5项评估肾移植后肾外狼疮 flare。
  • 7项研究比较血液透析与腹膜透析的肾外狼疮 flare 频率,4项研究比较血液透析/腹膜透析与肾移植的肾外狼疮 flare 频率,29项研究分析狼疮肾炎复发。
  • 采用森林图和随机效应模型评估终末期肾病或肾脏替代治疗后狼疮 flare 的比值比(95%置信区间),并用I²统计量评估研究异质性。

主要发现

  • 总体而言,35.9%的终末期肾病患者在肾脏替代治疗后至少发生一次肾外 flare。
  • 腹膜透析与血液透析的肾外狼疮 flare 频率相似(OR 1.05,95%CI 0.57-1.94)。
  • 腹膜透析/血液透析组肾外 flare 风险显著高于肾移植组(OR 4.36,95%CI 1.66-11.47;P=0.0028)。
  • 肾移植后狼疮肾炎复发率为3.39%。

关键数值与推荐

  • 腹膜透析与血液透析肾外狼疮 flare 频率比较:OR 1.05,95%CI 0.57-1.94。
  • 腹膜透析/血液透析与肾移植肾外狼疮 flare 风险比较:OR 4.36,95%CI 1.66-11.47;P=0.0028。
  • 终末期肾病患者肾脏替代治疗后至少一次肾外 flare 的比例为35.9%。
  • 肾移植后狼疮肾炎复发率为3.39%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In this study, we performed a systematic literature review and meta-analysis to assess the frequency of systemic lupus erythematosus (SLE) flares in patients with end-stage renal disease (ESRD) and patients undergoing renal replacement therapy (RRT), hemodialysis (HD), peritoneal dialysis (PD), and kidney transplant (KT). METHODS: Literature from 1973 to 2023 was searched for studies on the frequency of lupus flares after RRT. Data were extracted for ESRD and each RRT modality. Forest plots and random effect models were used to evaluate the odds ratios (95% confidence interval [CI]) of SLE flares after ESRD or RRT, and study heterogeneity was assessed using I2 statistics. RESULTS: A total of 57 studies fulfilled the study entry criteria. A total of 29 studies evaluated extrarenal SLE flares after HD/PD, and five studies evaluated extrarenal SLE flares after KT. The frequency of extrarenal SLE flares was compared between HD and PD in seven studies and between HD/PD and KT in four studies. The recurrence of lupus nephritis (LN) was analyzed in 29 studies. Overall, 35.9% of patients with ESRD had at least one extrarenal flare after RRT. The frequency of extrarenal SLE flare was similar in PD and HD (oods ratio [OR] 1.05, 95% CI 0.57-1.94). Extrarenal flare risk was significantly higher in the PD/HD group compared with that of the KT group (OR 4.36, 95% CI 1.66-11.47; P = 0.0028). The recurrence of LN after KT was 3.39%. CONCLUSION: Extrarenal lupus flares can still occur in more than one-third of patients with ESRD receiving RRT. Dialysis patients have a higher flare risk than those after KT, with comparable flare risk among patients receiving HD and PD.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Daoud A, Dweik L, Desai N, et al. Lupus Flares: More Common in Dialysis Patients Than in Post-Kidney Transplant Recipients: A Systematic Review and Meta-Analysis. Arthritis Care Res (Hoboken). 2025. PMID: 39936252. doi:10.1002/acr.25507

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。